VIRUPOS

This brand name is authorized in Australia, Germany, Hong Kong SAR China, Malta, New Zealand, Poland.

Active ingredients

The drug VIRUPOS contains one active pharmaceutical ingredient (API):

1	Aciclovir UNII X4HES1O11F - ACYCLOVIR
	Acyclovir is an antiviral agent with activity against herpes simplex virus and varicella-zoster virus. Acyclovir inhibits the DNA polymerase of the virus, preventing further proliferation.
	Read more about Aciclovir

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
VIRUPOS Eye ointment	MPI, EU: SmPC	Medicines and Medical Devices Safety Authority (NZ)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
S01AD03	Aciclovir	S Sensory organs → S01 Ophthalmologicals → S01A Antiinfectives → S01AD Antivirals
Discover more medicines within S01AD03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1002R, 5501M
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	07136323
HK	Department of Health Drug Office	60697
MT	Medicines Authority	AA565/52001
NZ	Medicines and Medical Devices Safety Authority	17704
PL	Rejestru Produktów Leczniczych	100177089